Objective: To validate a slightly modified sore throat pain model by compar
ing the analgesic efficacy of ibuprofen with that of paracetamol.
Design: A double-blind, double-dummy study was conducted.
Setting: Nineteen primary care centres in France.
Patients: Adults consulting their general practitioner with acute sore thro
at of a maximum of two days' duration.
Interventions: Patients (n = 113) with acute pain associated with tonsillo-
pharyngitis randomly received either 400mg ibuprofen or 1000mg paracetamol.
The study design included repeated administration up to 48 hours to assess
tolerability.
Main Outcome Measures: At hourly intervals for 6 hours after the first dose
of treatment, the patients evaluated pain intensity on swallowing, difficu
lty in swallowing and global pain relief according to visual analogue scale
s.
Results: Ibuprofen 400mg was significantly more effective than paracetamol
1000mg in all three ratings, at all time-points for pain intensity and diff
iculty in swallowing, and from two hours onwards for pain relief. There wer
e no serious adverse effects and no statistically significant difference in
the incidence of adverse events in the two treatment groups.
Conclusions: Sore throat pain provided a sensitive model to assess the anal
gesic efficacy of class I analgesics and discriminated between the analgesi
c efficacy of ibuprofen and paracetamol. Sore throat is a very common compl
aint and practising physicians should consider ibuprofen as an effective al
ternative to paracetamol in the treatment of sore throat pain. The sore thr
oat model should be considered by researchers as a sensitive assay of analg
esic activity.